ARVINAS, INC. ARVN
- ARV-027 — Spinal Bulbar Muscular Atrophy Phase 1
- luxdegalutamide — Metastatic Castration-Resistant Prostate Cancer Phase 3
- luxdegalutamide — Prostate Cancer Phase 1
Home › Targets › androgen receptor
androgen receptor (3 companies · 5 programs)
Companies with an active program directed at androgen receptor.
Fortress Biotech, Inc. FBIO
- AJ201
Viking Therapeutics, Inc. VKTX
- VK5211 — Hip Fracture Phase 2